Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × ceralasertib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Triple Negative Breast Neoplasms 4 Lung Neoplasms 4 Breast Neoplasms 3 Neoplasms 2 Endometrial Neoplasms 2 Carcinosarcoma 2 Advanced Solid Tumours 2 Uterine Cervical Neoplasms 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Solid Tumour Refractory to Conventional Treatment 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Melanoma 1 Lung Diseases 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 High Grade Serous Carcinoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Fallopian Tube Neoplasms 1

Interventions

Cyclophosphamide 58 Rituximab 47 fludarabine 38 fludarabine phosphate 25 obinutuzumab 17 venetoclax 16 Lenalidomide 16 ibrutinib 15 Etoposide 14 Prednisone 13 pirtobrutinib 12 Whole-Body Irradiation 12 Mycophenolic Acid 11 Melphalan 11 Bendamustine Hydrochloride 11 Tacrolimus 10 Specimen Handling 10 Filgrastim 10 Doxorubicin 10 Biopsy 10 Vincristine 9 Magnetic Resonance Spectroscopy 9 Granulocyte Colony-Stimulating Factor 9 pembrolizumab 8 Stem Cell Transplantation 8 Peripheral Blood Stem Cell Transplantation 8 Nivolumab 8 Gemcitabine 8 Cytarabine 8 tocilizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡